NGM BIOPHARMACEUTICALS INC Shareholders' Equity
NGM BIOPHARMACEUTICALS INC had Shareholders' Equity of $148.64 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-03-11
- 2023-12-31: Stockholders' Equity Attributable to Parent $148.64M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $169.81M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $192.12M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $220.93M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-12-31 | $148.64M 10-K · filed 2024-03-11 |
| 2023-09-30 | $169.81M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $192.12M 10-Q · filed 2023-11-02 |
| 2023-03-31 | $220.93M 10-Q · filed 2023-11-02 |
| 2022-12-31 | $259.56M 10-K · filed 2024-03-11 |
| 2022-09-30 | $285.89M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $292.08M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $311.14M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $335.65M 10-K · filed 2024-03-11 |
| 2021-09-30 | $354.04M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $373.07M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $399.58M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $280.04M 10-K · filed 2024-03-11 |
| 2020-09-30 | $276.70M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $301.16M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $318.97M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $330.72M 10-K · filed 2023-02-28 |
| 2019-09-30 | $339.19M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $346.13M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$119.18M 10-Q · filed 2020-11-12 |
| 2018-12-31 | -$108.19M 10-K · filed 2022-03-01 |
| 2018-09-30 | -$125.59M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$123.45M 10-Q · filed 2019-11-12 |
| 2018-03-31 | -$122.97M 10-Q · filed 2019-11-12 |
| 2017-12-31 | -$120.98M 10-K · filed 2021-03-15 |
| 2016-12-31 | -$115.06M 10-K · filed 2020-03-17 |